Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics

查看全文 作　　者：Jelena [1]Grahovac;Tatjana Srdic-[1]Rajic;Juan Francisco [2,3]Santibanez;Marijana [1]Pavlovic;Milena [1]Cavic;Sinisa [1]Radulovic1

机构地区：[1]Laboratory for Experimental Pharmacology, Institute for Oncology and Radiology of Serbia, Belgrade 11000, Serbia;[2]Department of Molecular Oncology, Institute for Medical Research, University of Belgrade, Belgrade 11000, Serbia;[3]Integrative Center for Biology and Applied Chemistry (CIBQA), Bernardo O'Higgins University, Santiago 8370854, Chile

出　　处：《Cancer Biology & Medicine》索引2019年第16卷第2期,共17页

基　　金：supported by grants from the Serbian Ministry for Education, Science and Technology Development (Grant No.III41026 and 175053) 摘　　要：Objective: Despite recent advancements in targeted therapy and immunotherapies, prognosis for metastatic melanoma patients remains extremely poor. Development of resistance to previously effective treatments presents a serious challenge and new approaches for melanoma treatment are urgently needed. The objective of this study was to examine the effects of telmisartan, an AGTR1 inhibitor and a partial agonist of PPARγ, on melanoma cells as a potential agent for repurposing in melanoma treatment.Methods: Expression of AGTR1 and PPARγ m RNA in melanoma patient tumor samples was examined in publicly available datasets and confirmed in melanoma cell lines by qRT-PCR. A panel of melanoma cell lines was tested in viability, apoptosis and metabolic assays in presence of telmisartan by flow cytometry and immunocytochemistry. A cytotoxic effect of combinations of telmisartan and targeted therapy vemurafenib was examined using the Chou-Talalay combination index method.Results: Both AGTR1 and PPARγ mRNA were expressed in melanoma patient tumor samples and decreased compared to the expression in the healthy skin. In vitro, we found that telmisartan decreased melanoma cell viability by inducing cell apoptosis.Increased glucose uptake, but not utilization, in the presence of telmisartan caused the fission of mitochondria and release of reactive oxygen species. Telmisartan altered the cell bioenergetics, thereby synergizing with vemurafenib in vitro, and even sensitized vemurafenib-resistant cells to the treatment.Conclusions: Given that the effective doses of telmisartan examined in our study can be administered to patients and that telmisartan is a widely used and safe antihypertensive drug, our findings provide the scientific rationale for testing its efficacy in treatment of melanoma progression. 关键词：MELANOMA TELMISARTAN apoptosis MITOCHONDRIA reactive oxygen species targeted therapy

相关文献

参考文献（54）
引证文献（4）
耦合文献（0）

参考文献(54)

引证文献(4)

互联网出版许可证新出网证(渝)字10号全国400电话 - 免长途话费

Telmisartan induces melanoma cell apoptosis and synergizes with vemurafenib in vitro by altering cell bioenergetics

参考文献(54)

引证文献(4)

用户提示